PDEX vs SN.L
PDEX: Pro-Dex manufactures precision surgical and dental power instruments used in operating rooms and dental practices across the healthcare sector. SN.L: A global medical technology leader focused on restoring patient mobility through advanced orthopedic, sports medicine, and wound care solutions.
Side-by-side fundamentals
| Metric | PDEX | SN.L | Edge |
|---|---|---|---|
| Price as of 2026-08-21 close | $65.67 | £10.74 | |
| Market cap as of 2026-08-24 | $210M | n/a | |
| P/E as of 2026-08-24 | 17.93 | n/a | |
| PEG as of 2026-08-24 | 0.62 | n/a | |
| Net margin as of 2026-08-24 | +16.1% | n/a | |
| Gross margin as of 2026-08-24 | +27.8% | n/a | |
| Operating margin as of 2026-08-24 | +14.5% | n/a | |
| ROE as of 2026-08-24 | +29.1% | n/a | |
| ROA as of 2026-08-24 | +18.3% | n/a | |
| Debt / equity as of 2026-08-24 | 0.41 | n/a | |
| Revenue growth (YoY) as of 2026-08-24 | +16.4% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +16.6% | n/a | |
| Beta as of 2026-08-24 | 0.07 | n/a | |
| 1-year return as of 2026-08-21 close | +36.8% | -22.8% | PDEX higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.